Zane Yang

Zane Yang

Company: ABM Therapeutics

Job title: Chief Medical Officer


Targeting MAPK Signalling Pathways to Stop GBM Tumor Cell Proliferation 12:00 pm

Introducing a new generation of brain penetrant BRAF inhibitors for GBM ABM-1310 for BRAF v600-mutant GBM tumors- Phase I study Clinical evidence of ABM-1310 in high grade gliomas including GBMRead more

day: Conference Day 2

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.